VALN logo
NASDAQ · VALNBiotechnologyUpdated Nov 2, 2026

Valneva SE ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Valneva SE (VALN) is -152.15%

According to Valneva SE’s latest financial reports and current stock price. The company's current ROE is -152.15%. This represents a change of 287.96% compared to the average of -39.22% of the last 4 quarters.

Valneva SE (VALN) Historical ROE (quarterly & annually)

How has VALN ROE performed in the past?

The mean historical ROE of Valneva SE over the last ten years is -44.63%. The current -152.15% ROE has changed 240.90% with respect to the historical average. Over the past ten years (40 quarters), VALN's ROE was at its highest in in the December 2021 quarter at 101.13%. The ROE was at its lowest in in the June 2022 quarter at -155.97%.

Quarterly (TTM)
Annual

Average

-44.63%

Median

-46.10%

Minimum

-108.50%

Maximum

2.28%

Valneva SE (VALN) ROE by Quarter and Year

Discovering the peaks and valleys of Valneva SE ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 6.35%

Maximum Annual ROE = 2.28%

Minimum Annual Increase = -156.61%

Minimum Annual ROE = -108.50%

Quarterly (TTM)
Annual
YearROEChange
2025-108.50%1.51%
2024-6.76%-91.46%
2023-79.09%21.33%
2022-65.19%51.44%
2021-43.04%-48.25%
2020-83.17%6.35%
2019-1.29%-156.61%
20182.28%-118.40%
2017-12.39%-74.80%
2016-49.16%244.15%

Valneva SE (VALN) Average ROE

How has VALN ROE performed in the past?

The current ROE of Valneva SE (VALN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-64.78%

5-year avg

-60.52%

10-year avg

-44.63%

Valneva SE (VALN) ROE vs. Peers

How is VALN’s ROE compared to its peers?

Valneva SE’s ROE is less than Novavax, Inc. (159.85%), greater than Vir Biotechnology, Inc. (-29.99%), greater than Arcturus Therapeutics Holdings Inc. (-46.54%), greater than GeoVax Labs, Inc. (-743.66%), greater than Vaxcyte, Inc. (-37.57%), greater than Moderna, Inc. (-39.20%), greater than Inovio Pharmaceuticals, Inc. (-1005.80%), greater than Evaxion Biotech A/S (-61.39%), greater than CEL-SCI Corporation (-202.14%), less than ImmunityBio, Inc. (134.99%),

Build a custom stock screener for Valneva SE (VALN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valneva SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Valneva SE (VALN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Valneva SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Valneva SE's ROE?

How is the ROE calculated for Valneva SE (VALN)?

What is the highest ROE for Valneva SE (VALN)?

What is the 3-year average ROE for Valneva SE (VALN)?

What is the 5-year average ROE for Valneva SE (VALN)?

How does the current ROE for Valneva SE (VALN) compare to its historical average?